Table 1 Clinical characteristics of control and type 2 diabetes groups.

From: FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease

Clinical characteristics

Control (n = 119)

Type 2 diabetes (n = 234)

p value

Age (years)

64 ± 12

62 ± 7

0.23

BMI (kg/m2)

28.8 ± 5.4

28.5 ± 5.0

0.59

Male (%)

60

51

0.14

CVD (%)

41

19

< 0.001

Smoking category

Yes

No

Ex

Yes

No

Ex

 

Smoking (%)

13

46

39

8.1

45.7

45.3

0.92

SBP (mmHg)

135 ± 19

139 ± 19

0.03

DBP (mmHg)

83 ± 12

81 ± 11

0.16

Total cholesterol (mmol/L)

4.7 ± 1.0

5.5 ± 1.2

< 0.001

HDL-C (mmol/L)

1.38 ± 0.51

1.25 ± 0.33

0.02

FKBPL (ng/ml)

1.82 ± 0.79

2.00 ± 0.93

0.07

FKBPL (ng/ml) adjusted for CVD status

1.79 ± 0.89

2.03 ± 0.90

0.02

  1. Continuous data are expressed as mean (standard deviation) and categorical data as the number of subjects (%). p values < 0.05 (statistically significant). Independent samples t-tests and χ2 tests were used as appropriate. HDL-C: High-density lipoprotein cholesterol; SBP: Systolic blood pressure; DBP: Diastolic blood pressure. p values <0.05 are in bold.
Back to article page